nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.109	0.302	CbGbCtD
Guanfacine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.068	0.189	CbGbCtD
Guanfacine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0632	0.175	CbGbCtD
Guanfacine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0465	0.129	CbGbCtD
Guanfacine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.029	0.0806	CbGbCtD
Guanfacine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0266	0.0738	CbGbCtD
Guanfacine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0181	0.0504	CbGbCtD
Guanfacine—NISCH—Podofilox—Etoposide—peripheral nervous system neoplasm	0.0094	0.592	CbGdCrCtD
Guanfacine—NISCH—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00647	0.408	CbGdCrCtD
Guanfacine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000813	0.0013	CcSEcCtD
Guanfacine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000812	0.0013	CcSEcCtD
Guanfacine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000811	0.0013	CcSEcCtD
Guanfacine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00081	0.0013	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00081	0.0013	CcSEcCtD
Guanfacine—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000808	0.00129	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000805	0.00129	CcSEcCtD
Guanfacine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000805	0.00129	CcSEcCtD
Guanfacine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000805	0.00129	CcSEcCtD
Guanfacine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000804	0.00129	CcSEcCtD
Guanfacine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000802	0.00128	CcSEcCtD
Guanfacine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000798	0.00128	CcSEcCtD
Guanfacine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000795	0.00127	CcSEcCtD
Guanfacine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000795	0.00127	CcSEcCtD
Guanfacine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000792	0.00127	CcSEcCtD
Guanfacine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000789	0.00126	CcSEcCtD
Guanfacine—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000788	0.00126	CcSEcCtD
Guanfacine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000786	0.00126	CcSEcCtD
Guanfacine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000786	0.00126	CcSEcCtD
Guanfacine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00078	0.00125	CcSEcCtD
Guanfacine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000775	0.00124	CcSEcCtD
Guanfacine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000775	0.00124	CcSEcCtD
Guanfacine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000775	0.00124	CcSEcCtD
Guanfacine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000774	0.00124	CcSEcCtD
Guanfacine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000774	0.00124	CcSEcCtD
Guanfacine—Rash—Topotecan—peripheral nervous system neoplasm	0.000773	0.00124	CcSEcCtD
Guanfacine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000773	0.00124	CcSEcCtD
Guanfacine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000772	0.00124	CcSEcCtD
Guanfacine—Headache—Topotecan—peripheral nervous system neoplasm	0.000768	0.00123	CcSEcCtD
Guanfacine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000767	0.00123	CcSEcCtD
Guanfacine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000767	0.00123	CcSEcCtD
Guanfacine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000767	0.00123	CcSEcCtD
Guanfacine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000766	0.00123	CcSEcCtD
Guanfacine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000766	0.00123	CcSEcCtD
Guanfacine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000766	0.00123	CcSEcCtD
Guanfacine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000764	0.00122	CcSEcCtD
Guanfacine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000764	0.00122	CcSEcCtD
Guanfacine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000762	0.00122	CcSEcCtD
Guanfacine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000762	0.00122	CcSEcCtD
Guanfacine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000761	0.00122	CcSEcCtD
Guanfacine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00076	0.00122	CcSEcCtD
Guanfacine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00076	0.00122	CcSEcCtD
Guanfacine—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.00076	0.00122	CcSEcCtD
Guanfacine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00076	0.00122	CcSEcCtD
Guanfacine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000758	0.00121	CcSEcCtD
Guanfacine—Rash—Melphalan—peripheral nervous system neoplasm	0.000757	0.00121	CcSEcCtD
Guanfacine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000757	0.00121	CcSEcCtD
Guanfacine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000754	0.00121	CcSEcCtD
Guanfacine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000751	0.0012	CcSEcCtD
Guanfacine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00075	0.0012	CcSEcCtD
Guanfacine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00075	0.0012	CcSEcCtD
Guanfacine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000748	0.0012	CcSEcCtD
Guanfacine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000742	0.00119	CcSEcCtD
Guanfacine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000734	0.00118	CcSEcCtD
Guanfacine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000733	0.00117	CcSEcCtD
Guanfacine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000729	0.00117	CcSEcCtD
Guanfacine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000729	0.00117	CcSEcCtD
Guanfacine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000727	0.00116	CcSEcCtD
Guanfacine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000726	0.00116	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000724	0.00116	CcSEcCtD
Guanfacine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000723	0.00116	CcSEcCtD
Guanfacine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000723	0.00116	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000716	0.00115	CcSEcCtD
Guanfacine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000714	0.00114	CcSEcCtD
Guanfacine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000713	0.00114	CcSEcCtD
Guanfacine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00071	0.00114	CcSEcCtD
Guanfacine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.00071	0.00114	CcSEcCtD
Guanfacine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000706	0.00113	CcSEcCtD
Guanfacine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000702	0.00113	CcSEcCtD
Guanfacine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000702	0.00113	CcSEcCtD
Guanfacine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000701	0.00112	CcSEcCtD
Guanfacine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.0007	0.00112	CcSEcCtD
Guanfacine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000696	0.00112	CcSEcCtD
Guanfacine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000694	0.00111	CcSEcCtD
Guanfacine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000694	0.00111	CcSEcCtD
Guanfacine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000683	0.00109	CcSEcCtD
Guanfacine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00068	0.00109	CcSEcCtD
Guanfacine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000679	0.00109	CcSEcCtD
Guanfacine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000673	0.00108	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00067	0.00107	CcSEcCtD
Guanfacine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000662	0.00106	CcSEcCtD
Guanfacine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000656	0.00105	CcSEcCtD
Guanfacine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000656	0.00105	CcSEcCtD
Guanfacine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000655	0.00105	CcSEcCtD
Guanfacine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000655	0.00105	CcSEcCtD
Guanfacine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000652	0.00105	CcSEcCtD
Guanfacine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000647	0.00104	CcSEcCtD
Guanfacine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000646	0.00104	CcSEcCtD
Guanfacine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000646	0.00103	CcSEcCtD
Guanfacine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000642	0.00103	CcSEcCtD
Guanfacine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00064	0.00103	CcSEcCtD
Guanfacine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000638	0.00102	CcSEcCtD
Guanfacine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000633	0.00101	CcSEcCtD
Guanfacine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000632	0.00101	CcSEcCtD
Guanfacine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000631	0.00101	CcSEcCtD
Guanfacine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000627	0.001	CcSEcCtD
Guanfacine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000626	0.001	CcSEcCtD
Guanfacine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000621	0.000995	CcSEcCtD
Guanfacine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000616	0.000986	CcSEcCtD
Guanfacine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000615	0.000986	CcSEcCtD
Guanfacine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00061	0.000977	CcSEcCtD
Guanfacine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000608	0.000974	CcSEcCtD
Guanfacine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000606	0.000972	CcSEcCtD
Guanfacine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000606	0.000972	CcSEcCtD
Guanfacine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000597	0.000958	CcSEcCtD
Guanfacine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000593	0.000951	CcSEcCtD
Guanfacine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000591	0.000947	CcSEcCtD
Guanfacine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000589	0.000943	CcSEcCtD
Guanfacine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000588	0.000942	CcSEcCtD
Guanfacine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000586	0.00094	CcSEcCtD
Guanfacine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000585	0.000938	CcSEcCtD
Guanfacine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000581	0.000932	CcSEcCtD
Guanfacine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000581	0.000931	CcSEcCtD
Guanfacine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000579	0.000928	CcSEcCtD
Guanfacine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000578	0.000927	CcSEcCtD
Guanfacine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.000926	CcSEcCtD
Guanfacine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000569	0.000912	CcSEcCtD
Guanfacine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000569	0.000912	CcSEcCtD
Guanfacine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000569	0.000912	CcSEcCtD
Guanfacine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000565	0.000905	CcSEcCtD
Guanfacine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000564	0.000903	CcSEcCtD
Guanfacine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.000899	CcSEcCtD
Guanfacine—Rash—Vincristine—peripheral nervous system neoplasm	0.00056	0.000898	CcSEcCtD
Guanfacine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00056	0.000897	CcSEcCtD
Guanfacine—Headache—Vincristine—peripheral nervous system neoplasm	0.000557	0.000892	CcSEcCtD
Guanfacine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000548	0.000878	CcSEcCtD
Guanfacine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000547	0.000877	CcSEcCtD
Guanfacine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000538	0.000862	CcSEcCtD
Guanfacine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000535	0.000857	CcSEcCtD
Guanfacine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000531	0.000851	CcSEcCtD
Guanfacine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00053	0.00085	CcSEcCtD
Guanfacine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00053	0.000849	CcSEcCtD
Guanfacine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000528	0.000846	CcSEcCtD
Guanfacine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.000844	CcSEcCtD
Guanfacine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000516	0.000828	CcSEcCtD
Guanfacine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000513	0.000822	CcSEcCtD
Guanfacine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000509	0.000816	CcSEcCtD
Guanfacine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.000812	CcSEcCtD
Guanfacine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000804	CcSEcCtD
Guanfacine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0005	0.000801	CcSEcCtD
Guanfacine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000495	0.000794	CcSEcCtD
Guanfacine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000495	0.000793	CcSEcCtD
Guanfacine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000492	0.000789	CcSEcCtD
Guanfacine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000491	0.000787	CcSEcCtD
Guanfacine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.000785	CcSEcCtD
Guanfacine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000777	CcSEcCtD
Guanfacine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000484	0.000776	CcSEcCtD
Guanfacine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00048	0.00077	CcSEcCtD
Guanfacine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000476	0.000763	CcSEcCtD
Guanfacine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000475	0.000762	CcSEcCtD
Guanfacine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000761	CcSEcCtD
Guanfacine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000467	0.000748	CcSEcCtD
Guanfacine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000747	CcSEcCtD
Guanfacine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000744	CcSEcCtD
Guanfacine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000459	0.000735	CcSEcCtD
Guanfacine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000458	0.000733	CcSEcCtD
Guanfacine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000728	CcSEcCtD
Guanfacine—Rash—Etoposide—peripheral nervous system neoplasm	0.000454	0.000727	CcSEcCtD
Guanfacine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000453	0.000727	CcSEcCtD
Guanfacine—Headache—Etoposide—peripheral nervous system neoplasm	0.000451	0.000723	CcSEcCtD
Guanfacine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000719	CcSEcCtD
Guanfacine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.000718	CcSEcCtD
Guanfacine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000714	CcSEcCtD
Guanfacine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000444	0.000712	CcSEcCtD
Guanfacine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000712	CcSEcCtD
Guanfacine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000443	0.000711	CcSEcCtD
Guanfacine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000705	CcSEcCtD
Guanfacine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000437	0.0007	CcSEcCtD
Guanfacine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000435	0.000696	CcSEcCtD
Guanfacine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000691	CcSEcCtD
Guanfacine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000428	0.000686	CcSEcCtD
Guanfacine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000428	0.000685	CcSEcCtD
Guanfacine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000684	CcSEcCtD
Guanfacine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.00068	CcSEcCtD
Guanfacine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000675	CcSEcCtD
Guanfacine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000675	CcSEcCtD
Guanfacine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000675	CcSEcCtD
Guanfacine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000674	CcSEcCtD
Guanfacine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000672	CcSEcCtD
Guanfacine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000666	CcSEcCtD
Guanfacine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000661	CcSEcCtD
Guanfacine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000412	0.00066	CcSEcCtD
Guanfacine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000659	CcSEcCtD
Guanfacine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000657	CcSEcCtD
Guanfacine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000652	CcSEcCtD
Guanfacine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000648	CcSEcCtD
Guanfacine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000647	CcSEcCtD
Guanfacine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.000644	CcSEcCtD
Guanfacine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000636	CcSEcCtD
Guanfacine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.000635	CcSEcCtD
Guanfacine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000633	CcSEcCtD
Guanfacine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000631	CcSEcCtD
Guanfacine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000625	CcSEcCtD
Guanfacine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000624	CcSEcCtD
Guanfacine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000624	CcSEcCtD
Guanfacine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000624	CcSEcCtD
Guanfacine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.000622	CcSEcCtD
Guanfacine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000617	CcSEcCtD
Guanfacine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.00061	CcSEcCtD
Guanfacine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000604	CcSEcCtD
Guanfacine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000603	CcSEcCtD
Guanfacine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000598	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000589	CcSEcCtD
Guanfacine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000589	CcSEcCtD
Guanfacine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000585	CcSEcCtD
Guanfacine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000584	CcSEcCtD
Guanfacine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000581	CcSEcCtD
Guanfacine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000578	CcSEcCtD
Guanfacine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000576	CcSEcCtD
Guanfacine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000575	CcSEcCtD
Guanfacine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000355	0.000569	CcSEcCtD
Guanfacine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000562	CcSEcCtD
Guanfacine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000559	CcSEcCtD
Guanfacine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000557	CcSEcCtD
Guanfacine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000553	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000545	CcSEcCtD
Guanfacine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000541	CcSEcCtD
Guanfacine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000537	CcSEcCtD
Guanfacine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000533	CcSEcCtD
Guanfacine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000533	CcSEcCtD
Guanfacine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000532	CcSEcCtD
Guanfacine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000529	CcSEcCtD
Guanfacine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000527	CcSEcCtD
Guanfacine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.00052	CcSEcCtD
Guanfacine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000516	CcSEcCtD
Guanfacine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000512	CcSEcCtD
Guanfacine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000511	CcSEcCtD
Guanfacine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000493	CcSEcCtD
Guanfacine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000489	CcSEcCtD
Guanfacine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000476	CcSEcCtD
Guanfacine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000473	CcSEcCtD
Guanfacine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000464	CcSEcCtD
Guanfacine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000457	CcSEcCtD
Guanfacine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000442	CcSEcCtD
Guanfacine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000441	CcSEcCtD
Guanfacine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000429	CcSEcCtD
Guanfacine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000428	CcSEcCtD
Guanfacine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000423	CcSEcCtD
Guanfacine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000411	CcSEcCtD
Guanfacine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000409	CcSEcCtD
Guanfacine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000408	CcSEcCtD
Guanfacine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000407	CcSEcCtD
Guanfacine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000405	CcSEcCtD
Guanfacine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000396	CcSEcCtD
Guanfacine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000384	CcSEcCtD
Guanfacine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.00038	CcSEcCtD
Guanfacine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000377	CcSEcCtD
Guanfacine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000377	CcSEcCtD
Guanfacine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000375	CcSEcCtD
Guanfacine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000355	CcSEcCtD
